Literature DB >> 12959282

Cigarette smoking enhances the elimination of quinine.

S Wanwimolruk1, S M Wong, P F Coville, S Viriyayudhakorn, S Thitiarchakul.   

Abstract

The pharmacokinetics of a single dose (600 mg) of quinine sulphate were examined in a group of non-smokers (n = 10) and in heavy cigarette smokers (n = 10). The mean (+/- s.d.) oral clearance of quinine in smokers (0.189 +/- 0.075 1 h(-1) kg(-1)) was significantly greater than in non-smokers (0.107 +/- 0.045 1 h(-1) kg(-1) , P < 0.01). The unbound clearance of quinine which reflects activity of the drug-metabolizing enzyme, was considerably greater (1.5-fold) in the smokers than in the non-smoker subjects. The mean elimination half-life of quinine in smokers was 7.5 +/- 1.4 (s.d.) h, significantly shorter (P < 0.005) than the mean value in non-smokers (12.0 +/- 3.1 h). These results suggest that cigarette smoking enhances the elimination of quinine. The clinical significance of these findings is unknown but they indicate the need for caution in the administration of quinine to patients who are heavy cigarette smokers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 12959282      PMCID: PMC1364670          DOI: 10.1111/j.1365-2125.1993.tb00424.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.

Authors:  R E Vestal; A H Norris; J D Tobin; B H Cohen; N W Shock; R Andres
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

2.  Effect of smoking on theophylline disposition.

Authors:  S N Hunt; W J Jusko; A M Yurchak
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

3.  Absorption and disposition of chlordiazepoxide in young and elderly male volunteers.

Authors:  R I Shader; D J Greenblatt; J S Harmatz; K Franke; J Koch-Weser
Journal:  J Clin Pharmacol       Date:  1977 Nov-Dec       Impact factor: 3.126

4.  The influence of cigarette smoking and sex on theophylline disposition.

Authors:  J R Powell; J F Thiercelin; S Vozeh; L Sansom; S Riegelman
Journal:  Am Rev Respir Dis       Date:  1977-07

5.  Phenacetin metabolism: effect of hydrocarbons and cigarette smoking.

Authors:  R Kuntzman; E J Pantuck; S A Kaplan; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

6.  Pharmacokinetics of quinine in young and elderly subjects.

Authors:  S Wanwimolruk; S Chalcroft; P F Coville; A J Campbell
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Nov-Dec       Impact factor: 2.184

7.  Quinine disposition kinetics.

Authors:  N J White; P Chanthavanich; S Krishna; C Bunch; K Silamut
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

8.  Enhanced drug metabolism in cigarette smokers.

Authors:  P Hart; G C Farrell; W G Cooksley; L W Powell
Journal:  Br Med J       Date:  1976-07-17

9.  Decreased concentration of phenacetin in plasma of cigarette smokers.

Authors:  E J Pantuck; R Kuntzman; A H Conney
Journal:  Science       Date:  1972-03-17       Impact factor: 47.728

10.  Treatment of angina pectoris with propranolol: the harmful effects of cigarette smoking.

Authors:  J Deanfield; A Jonathan; A Selwyn; K M Fox
Journal:  Cardiology       Date:  1981       Impact factor: 1.869

View more
  7 in total

Review 1.  Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs.

Authors:  P A De Smet; J R Brouwers
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

2.  Effects of long-term smoking on the activity and mRNA expression of CYP isozymes in rats.

Authors:  Xiao-Meng He; Ying Zhou; Ming-Zhen Xu; Yang Li; Hu-Qun Li; Wei-Yong Li
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 3.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

4.  Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.

Authors:  S M D K Ganga Senarathna; Kevin T Batty
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

5.  Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man.

Authors:  S Wanwimolruk; W Kang; P F Coville; S Viriyayudhakorn; S Thitiarchakul
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

6.  Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4?

Authors:  Sompon Wanwimolruk; Mary F Paine; Susan N Pusek; Paul B Watkins
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 7.  New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Authors:  Emma Beard; Lion Shahab; Damian M Cummings; Susan Michie; Robert West
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 5.749

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.